Advances in the treatment of chronic atrophic gastritis with a combination of Chinese and Western medicine and the public health implications-Reference-Cited by-同舟云学术

Advances in the treatment of chronic atrophic gastritis with a combination of Chinese and Western medicine and the public health implications

Published:2022-07-27 Issue: Volume:6 Page:364-371
ISSN:2791-0210
Container-title:Highlights in Science, Engineering and Technology
language:
Short-container-title:HSET

Author:

Ma Mingyi,Qi Jingjing,Jiang Rongqin

Abstract

Chronic atrophic gastritis (CAG) is a disease characterized by atrophy of the gastric mucosa and reduction of intrinsic glands, accompanied by intestinal hyperplasia and/or pseudopyloric glandular hyperplasia, and is a common clinical gastrointestinal lesion that can be produced by the interaction of multiple factors. The pathogenesis of CAG has not been completely clarified, and there are no specific drugs or treatment methods, and the disease is prone to recurrence. The pathogenesis of CAG is not fully understood, and there is no specific drug or treatment, and the disease is prone to recurrence. This paper reviews the treatment progress and public health implications of Western medicine, Chinese medicine, and the combination of Western and Chinese medicine in the treatment of chronic atrophic gastritis, in order to provide some reference for the clinical treatment and public prevention of chronic atrophic gastritis.

Publisher

Darcy & Roy Press Co. Ltd.

Reference49 articles.

1. Xu WC,Xu Yl,Zhang ZB,et al. A study on the pattern of medication for chronic atrophic gastritis in Beijing-Tianjin-Hebei region based on the hidden structure model of evidence-based treatment by famous old Chinese medicine experts[J]. Chinese Journal of Traditional Chinese Medicine,2020(7):1691-1697.

2. Deng DH, Huang ZB, Zhou H. Clinical efficacy of Tiao Zhong Yi Qi Tang plus and minus combined with recruitment and matching point moxibustion in the treatment of chronic atrophic gastritis with evidence of spleen and stomach weakness [J]. Sichuan Traditional Chinese Medicine, 2021, 39(5): 99-101.

3. Chinese Society of Traditional Chinese Medicine, Branch of Spleen and Stomach Diseases. Consensus opinion on Chinese medicine treatment of chronic atrophic gastritis (Shenzhen, 2009) [J]. Chinese Journal of Integrative Medicine and Digestion, 2010, 18(5):345-349.

4. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interob server consistency using new criteria for classification and grading [J]. Aliment Pharmacol Ther, 2002, 1 6(7):1 249-1 259.

5. Chinese Medical Association, Gastroenterology Branch . Consensus opinion on chronic gastritis in China (2017, Shanghai) [J]. Chinese Journal of Gastroenterology, 2017, 37(11):721-738.